Medical/Pharmaceuticals

A Decade of Reforming the Japanese Health Care System: OmiGroup Unveils New Brand Identity and The Pioneer Mission for Japan Digital Healthcare

TOKYO, June 19, 2023 /PRNewswire/ -- OmiGroup , a prominent brand, has recently undergone a significant transformation, introducing a refreshed logo and redefined core values. However, amidst these changes, the company remains steadfast in pre...

2023-06-21 16:00 2495

Manulife Hong Kong Expands its Designated China Hospital Network

* Expanded network now covers over 3,000 listed hospitals across Mainland China * First life insurer in Hong Kong to offer network coverage for all of China's Grade III public hospitals HONG KONG, June 21, 2023 /PRNewswire/ -- Manulife Hong Kong announced today the expansion of its Designated...

2023-06-21 10:40 5657

Mediso receives FDA approval for InterView™ nuclear medicine image processing software

BUDAPEST, Hungary, June 21, 2023 /PRNewswire/ -- Mediso has announced the Food and Drug Administration (FDA) clearance of theInterView™ FUSION andInterView™ XP

2023-06-21 09:00 3093

Everest Medicines' Partner Calliditas Therapeutics Makes Data Presentations on Nefecon at European Renal Association - European Dialysis and Transplant Association Congress (ERA-EDTA )

SHANGHAI, June 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") made presentations on data from the NeflgArd Phase 3 Study at the European Renal...

2023-06-21 08:15 4544

Telix Urology Innovation Showcase to be held at The Yale Club, New York City

MELBOURNE, Australia and INDIANAPOLIS, June 21, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an outline agenda for the Company's briefing session for shareholders to be held on Wednesday, June 21, 2023, at The Yale Club in New York City, from 8.3...

2023-06-21 06:31 2737

IBC Launches Full Range of Best-in-Class Molecular Recognition Technology™ (MRT™) Flowsheets for Highly Selective Separations of Key Radionuclides and Preparation of Novel Chelating Agents for Radionuclide Incorporation into Radiopharmaceuticals

* Development of multiple anticancer drugs with radioisotopes is in progress * Lu-177, Y-90, Cu-67, Ra-223, Ac-225, Pb-212 and At-211 have licensed products or are in clinical trials * IBC's state-of-the-art MRT™ separation and chelation technologies facilitate production of radiopharmaceuti...

2023-06-20 22:21 3039

Subang Jaya Medical Centre Awarded Frost & Sullivan's Company of the Year Award for the Third Consecutive Year

SJMC's long history of clinical and service excellence and expertise in certain areas, such as oncology and orthopedics, points to its robust performance. SAN ANTONIO, June 20, 2023 /PRNewswire/ -- Frost & Sullivan assessed the Malaysian healthcare industry and, based on its findings, recognizesS...

2023-06-20 09:00 1403

Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster

PHILADELPHIA, June 20, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has tapped Irena Lerentracht Webster to join its board of directors.Webster is...

2023-06-20 07:00 1291

AWAK Technologies and Singapore General Hospital launch pre-pivotal clinical trial of wearable peritoneal dialysis device

SINGAPORE, June 20, 2023 /PRNewswire/ -- AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announce the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dial...

2023-06-20 06:00 2159

Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 19, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company"; stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced the adv...

2023-06-19 21:29 4068

Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients

ALHAMBRA, Calif., June 19, 2023 /PRNewswire/ -- Allgenesis Biotherapeutics Inc., a clinical-stage specialty pharmaceutical company focused on developing novel ophthalmic drugs, today announced topline data from the company's Phase1b clinical trial for AG-80308, a first-in-class, formyl peptide re...

2023-06-19 16:00 1670

Novel Transcatheter Valve Repair Device: DRAGONFLY-DMR 12-Month Trial Results Revealed at EuroPCR 2023

First-Time Clinical Trial Outcomes Show Promising Follow-Up Results HANGZHOU, China, June 19, 2023 /PRNewswire/ -- On May 17th, the 12-month results of the DRAGONFLY-DMR pivotal trial were presented at EuroPCR 2023. This trial was led by Professor Jian'an Wang from Zhe'er Hospital,Hangzhou, China...

2023-06-19 14:35 1720

TCM contributes "Chinese scripts" to Cambodia's epidemic prevention, global health governance

BEIJING, June 19, 2023 /PRNewswire/ -- A news report by haiwainet.cn:  In recent years, Chinese hospitals, represented by Xiyuan Hospital under the China Academy of Chinese Medical Sciences, have made remarkable progress in overseas traditional Chinese medicine(TCM) clinics, training and exchange...

2023-06-19 13:51 1626

First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion

MELBOURNE, Australia, June 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II study of the Company's carbonic anhydrase- (CAIX)-targeting PET/CT[1] imaging agent TLX250-CDx (89Zr-DFO-girentuxima...

2023-06-19 08:16 1991

Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients

- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its use as a treatment for heart transplant rejection and prevention of rejection1 - DUBLIN, June 19, 2023 /PR...

2023-06-19 06:30 2683

The 'Penicillin' of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug

- Professor Heungjeong Woo of Hallym University College of Medicine, announced the result of Xafty's clinical study at Emerging Science Session of the American Society for Microbiology (ASM) Microbe 2023 - Dr. Jo White evaluated Xafty's clinical results as "The birth of Penicillin of Antivirals"...

2023-06-18 03:30 4103

Molfix Bond with Love Secure Attachment Bond Program was Honored with The International CSR Excellence Awards in its 5th Year

Bond with Love Secure Attachment Bond Program of Molfix, which supports the happy and healthy development of babies and is a reliable companion of mothers with its innovative approach, was honored with "The International CSR Excellence Awards" LONDON, June 17, 2023 /PRNewswire/ -- Molfix Bond wi...

2023-06-17 13:00 3230

MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE

SUZHOU, China, June. 17, 2023  /PRNewswire/ -- The 4th Academic Annual Conference held by the Mechanical Circulatory Support (MCS) Branch of the Chinese Society of Biomedical Engineering (CSBE), one of the biggest academic gatherings that celebrate the latest accomplishments in technological inn...

2023-06-17 07:08 4010

Apollo Hospitals Eliminates 2,90,000 Tons of Carbon with Smart Joules, Strengthening India's Decarbonization Efforts

NEW DELHI, June 16, 2023 /PRNewswire/ -- Apollo Hospitals, the world's largest vertically integrated healthcare provider, has joined hands with Smart Joules to reduce carbon emissions by an astounding 2,90,000 tons, bolsteringIndia's efforts to decarbonize. This ten-year initiative spans 18 hospi...

2023-06-16 15:33 3322

Wellness expert Ananchi introduces new Japanese technology, offers advanced bust beauty care and fertility treatments with new center in Central Hong Kong

HONG KONG, June 16, 2023 /PRNewswire/ -- Wellness and beauty expert Ananchi today announces the opening of a new center inCentral Hong Kong, and unveils a multi-million dollar expansion plan which includes investment in the latest health and wellness technology. Since its inception in 2019, Ananc...

2023-06-16 15:00 2327
1 ... 100101102103104105106 ... 397

Week's Top Stories